New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Bellizzi, Anna ^a   Anzivino, Elena ^a   Rodio, Donatella Maria ^a   Palamara, Anna Teresa ^a,b   Nencioni, Lucia ^a   Pietropaolo, Valeria ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; EFALIZUMAB; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; JANUS KINASE; NATALIZUMAB; PROTEIN MAD1; RAG1 PROTEIN; RAG2 PROTEIN; RITUXIMAB; STAT PROTEIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA; MONOCLONAL ANTIBODY;

AUTOIMMUNE DISEASE; BINDING SITE; CLINICAL FEATURE; DNA REPLICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOSURVEILLANCE; JC VIRUS; LYSIS; OLIGODENDROGLIA; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REACTIVATION; BRAIN; DRUG EFFECTS; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; PATHOLOGY; VIROLOGY; VIRUS ACTIVATION; DRUG EFFECT;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; BRAIN; GENE EXPRESSION REGULATION, VIRAL; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC SURVEILLANCE; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; VIRUS ACTIVATION;

EID: 84877249541     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/839719     Document Type: Review

References (124)

1. Padgett B. L., Walker D. L., ZuRhein G. M., Eckroade R. J., Dessel B. H., Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. The Lancet 1971 1 7712 1257 1260 2-s2.0-0015232447
2. Åström K. E., Mancall E. L., Richardson E. P. Jr., Progressive multifocal leuko-encephalopathy, a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958 81 1 93 111 10.1093/brain/81.1.93
3. Brew B. J., Davies N. W. S., Cinque P., Clifford D. B., Nath A., Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nature Reviews Neurology 2010 6 12 667 679 2-s2.0-78649969090 10.1038/nrneurol.2010.164
4. Bellizzi A., Nardis C., Anzivino E., Rodìo D. M., Fioriti D., Mischitelli M., Chiarini F., Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. Journal of Neurovirology 2012 18 1 1 11 10.1007/s13365-012-0080-7
5. Del Valle L., Khalili K., Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays. Journal of Medical Virology 2010 82 5 806 811 2-s2.0-77950988846 10.1002/jmv.21514
6. Tan C. S., Koralnik I. J., Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. The Lancet Neurology 2010 9 4 425 437 2-s2.0-77949297173 10.1016/S1474-4422(10) 70040-5
7. Weissert R., Progressive multifocal leukoencephalopathy. Journal of Neuroimmunology 2011 231 1-2 73 77 2-s2.0-79952444229 10.1016/j.jneuroim.2010. 09.021
8. Major E. O., Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annual Review of Medicine 2010 61 35 47 2-s2.0-77949375380 10.1146/annurev.med.080708.082655
9. Orba Y., Suzuki T., Makino Y., Kubota K., Tanaka S., Kimura T., Sawa H., Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. Journal of Biological Chemistry 2010 285 2 1544 1554 2-s2.0-74049130966 10.1074/jbc.M109.064311
10. Del Valle L., Gordon J., Assimakopoulou M., Enam S., Geddes J. F., Varakis J. N., Katsetos C. D., Croul S., Khalili K., Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Research 2001 61 10 4287 4293 2-s2.0-0035872427 (Pubitemid 32721002)
11. Bollag B., Kilpatrick L. H., Tyagarajan S. K., Tevethia M. J., Frisque R. J., JC virus T′135, T′136 and T′165 proteins interact with cellular p107 and p130 in vivo and influence viral transformation potential. Journal of NeuroVirology 2006 12 6 428 442 2-s2.0-33845489472 10.1080/13550280601009553 (Pubitemid 44911564)
12. Bollag B., Hofstetter C. A., Reviriego-Mendoza M. M., Frisque R. J., JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PloS one 2010 5 5 e10606 2-s2.0-77956293690 10.1371/journal.pone.0010606
13. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W. W., Sawa H., The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathogens 2010 6 3 2-s2.0-77950444850 10.1371/journal.ppat. 1000801 e1000801
14. Pietropaolo V., Videtta M., Fioriti D., Mischitelli M., Arancio A., Orsi N., Degener A. M., Rearrangement patterns of JC virus noncoding control region from different biological samples. Journal of NeuroVirology 2003 9 6 603 611 2-s2.0-0346147036 (Pubitemid 37536716)
15. Mischitelli M., Fioriti D., Videtta M., Degener A. M., Antinori A., Cinque P., Giordano A., Pietropaolo V., Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. Journal of Cellular Physiology 2005 204 3 913 918 2-s2.0-23244434614 10.1002/jcp.20375 (Pubitemid 41099277)
16. Marshall L. J., Major E. O., Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. Journal of Neuroimmune Pharmacology 2010 5 3 404 417 2-s2.0-77955982121 10.1007/s11481-010-9203-1
17. Frisque R. J., Nucleotide sequence of the region encompassing the JC virus origin of DNA replication. Journal of Virology 1983 46 1 170 176 2-s2.0-0020693742 (Pubitemid 13161256)
18. White M. K., Safak M., Khalili K., Regulation of gene expression in primate polyomaviruses. Journal of Virology 2009 83 21 10846 10856 2-s2.0-70350306663 10.1128/JVI.00542-09
19. Wortman M. J., Krachmarov C. P., Kim J. H., Gordon R. G., Chepenik L. G., Brady J. N., Gallia G. L., Johnson E. M., Interaction of HIV-1 Tat with pur α in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding. Journal of Cellular Biochemistry 2000 77 1 65 74 (Pubitemid 30126895)
20. Daniel D. C., Wortman M. J., Schiller R. J., Liu H., Gan L., Mellen J. S., Chang C. F., Gallia G. L., Rappaport J., Khalili K., Johnson E. M., Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Pur α on DNA replication initiated at the JC virus origin. Journal of General Virology 2001 82 7 1543 1553 2-s2.0-0034959094 (Pubitemid 32611494)
21. Post M. J. D., Yiannoutsos C., Simpson D., Booss J., Clifford D. B., Cohen B., McArthur J. C., Hall C. D., Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? American Journal of Neuroradiology 1999 20 10 1896 1906
22. Thurnher M. M., Post M. J. D., Rieger A., Kleibl-Popov C., Loewe C., Schindler E., Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. American Journal of Neuroradiology 2001 22 5 977 984 2-s2.0-0035039782 (Pubitemid 32436244)
23. Major E. O., Ault G. S., Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Current Opinion in Neurology 1995 8 3 184 190 2-s2.0-0029068057
24. Tyler K. L., Emerging viral infections of the central nervous system: part 2. Archives of Neurology 2009 66 9 1065 1074 10.1001/archneurol.2009.189
25. Monaco M. C. G., Jensen P. N., Hou J., Durham L. C., Major E. O., Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. Journal of Virology 1998 72 12 9918 9923 2-s2.0-0031798275 (Pubitemid 28520858)
26. Chapagain M. L., Nerurkar V. R., Human polyomavirus JC (JCV) infection of luman B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. Journal of Infectious Diseases 2010 202 2 184 191 2-s2.0-77954594238 10.1086/653823
27. Jiang M., Abend J. R., Johnson S. F., Imperiale M. J., The role of polyomaviruses in human disease. Virology 2009 384 2 266 273 2-s2.0-59349105146 10.1016/j.virol.2008.09.027
28. White M. K., Khalili K., Pathogenesis of progressive multifocal leukoencephalopathy-revisited. Journal of Infectious Diseases 2011 203 5 578 586 2-s2.0-79751493943 10.1093/infdis/jiq097
29. Manley K., O'Hara B. A., Gee G. V., Simkevich C. P., Sedivy J. M., Atwood W. J., NFAT4 is required for JC virus infection of glial cells. Journal of Virology 2006 80 24 12079 12085 2-s2.0-33845455486 10.1128/JVI.01456-06 (Pubitemid 44904358)
30. Wollebo H. S., Safak M., Del Valle L., Khalili K., White M. K., Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy. Journal of Neuroimmunology 2011 233 1-2 46 53 2-s2.0-79953297924 10.1016/j.jneuroim.2010.11.013
31. Romagnoli L., Wollebo H. S., Deshmane S. L., Mukerjee R., Del Valle L., Safak M., Khalili K., White M. K., Modulation of JC virus transcription by C/EBP β Virus Research 2009 146 1-2 97 106 10.1016/j.virusres.2009.09.005
32. Ghosh S., Karin M., Missing pieces in the NF-kappaB puzzle. Cell 2002 109 supplement S81 S96
33. Ramji D. P., Foka P., CCAAT/enhancer-binding proteins: structure, function and regulation. The Biochemical Journal 2002 365 3 561 575 (Pubitemid 34864439)
34. Hu B., Wu Z., Jin H., Hashimoto N., Liu T., Phan S. H., CCAAT/enhancerbinding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta. The Journal of Immunology 2004 173 7 4661 4668 (Pubitemid 39280700)
35. Perez-Liz G., Del Valle L., Gentilella A., Croul S., Khalili K., Detection of JC virus DNA fragments but not proteins in normal brain tissue. Annals of Neurology 2008 64 4 379 387 2-s2.0-55849085378 10.1002/ana.21443
36. Mitoma H., Horiuchi T., Hatta N., Tsukamoto H., Harashima S. I., Kikuchi Y., Otsuka J., Okamura S., Fujita S., Harada M., Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF- α Gastroenterology 2005 128 2 376 392 2-s2.0-14944382276 10.1053/j.gastro.2004.11.060 (Pubitemid 40431090)
37. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., Nourse J., Crabtree G. R., The mechanism of action of cyclosporin A and FK506. Clinical Immunology and Immunopathology 1996 80 3 S40 S45 2-s2.0-0029797189 10.1006/clin.1996.0140 (Pubitemid 26317357)
38. Bellizzi A., Anzivino E., Ferrari F., Di Nardo G., Colosimo M. T., Fioriti D., Mischitelli M., Chiarini F., Cucchiara S., Pietropaolo V., Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. Journal of NeuroVirology 2011 17 4 303 313 10.1007/s13365-011-0036-3
39. Lindberg R. L. P., Achtnichts L., Hoffmann F., Kuhle J., Kappos L., Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of Neuroimmunology 2008 194 1-2 153 164 2-s2.0-39849089879 10.1016/j.jneuroim.2007.11.007
40. Gallant S., Gilkeson G., ETS transcription factors and regulation of immunity. Archivum Immunologiae et Therapiae Experimentalis 2006 54 3 149 163 2-s2.0-33747497812 10.1007/s00005-006-0017-z (Pubitemid 44257335)
41. Schmidlin H., Diehl S. A., Nagasawa M., Scheeren F. A., Schotte R., Uittenbogaart C. H., Spits H., Blom B., Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 2008 112 5 1804 1812 2-s2.0-52649102382 10.1182/blood-2008-01-136440
42. Del Valle L., White M. K., Khalili K., Potential mechanisms of the human polyomavirus JC in neural oncogenesis. Journal of Neuropathology and Experimental Neurology 2008 67 8 729 740 2-s2.0-52249093352 10.1097/NEN. 0b013e318180e631
43. + T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. Journal of Virology 2007 81 8 3361 3368 10.1128/JVI.01809-06 (Pubitemid 46456645)
44. Padgett B. L., Walker D. L., Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 1973 127 4 467 470 2-s2.0-0015611076
45. Kean J. M., Rao S., Wang M., Garcea R. L., Seroepidemiology of human polyomaviruses. PLoS Pathogens 2009 5 3 e1000363 2-s2.0-63449123993 10.1371/journal.ppat.1000363
46. Weber F., Goldmann C., Krämer M., Kaup F. J., Pickhardt M., Young P., Petry H., Weber T., Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Annals of Neurology 2001 49 5 636 642 10.1002/ana.1004 (Pubitemid 32429790)
47. Houff S. A., Berger J. R., The bone marrow, B cells, and JC virus. Journal of Neurovirology 2008 14 5 341 343 10.1080/13550280802348222 (Pubitemid 352762873)
48. Lima M. A., Bernal-Cano F., Clifford D. B., Gandhi R. T., Koralnik I. J., Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. Journal of Neurology, Neurosurgery and Psychiatry 2010 81 11 1288 1291 2-s2.0-78649595709 10.1136/jnnp.2009.179002
49. +T cells with JCV-infected glial cells. Journal of NeuroVirology 2006 12 2 116 128 2-s2.0-33746822397 10.1080/13550280600716604 (Pubitemid 44590938)
50. + cytotoxic T-cell responses during chronic viral infection. Journal of Virology 1994 68 12 8056 8063 2-s2.0-0027971622 (Pubitemid 24362694)
51. Berger J. R., Houff S., Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurological Research 2006 28 3 299 305 2-s2.0-33646788719 10.1179/016164106X98198 (Pubitemid 43765116)
52. Carter C. C., Onafuwa-Nuga A., McNamara L. A., Riddell J., Bixby D., Savona M. R., Collins K. L., HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nature Medicine 2010 16 4 446 451 2-s2.0-77950531446 10.1038/nm.2109
53. Ferenczy M. W., Marshall L. J., Nelson C. D. S., Atwood W. J., Nath A., Khalili K., Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clinical Microbiology Reviews 2012 25 3 471 506 10.1128/CMR.05031-11
54. Daniel D. C., Kinoshita Y., Khan M. A., Del Valle L., Khalili K., Rappaport J., Johnson E. M., Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA and Cell Biology 2004 23 12 858 867 2-s2.0-10344253813 10.1089/dna.2004.23.858 (Pubitemid 39628294)
55. Nukuzuma S., Nakamichi K., Kameoka M., Sugiura S., Nukuzuma C., Miyoshi I., Takegami T., Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiology and Immunology 2010 54 12 758 762 2-s2.0-78649500451 10.1111/j.1348-0421.2010.00278.x
56. Stettner M. R., Nance J. A., Wright C. A., Kinoshita Y., Kim W. K., Morgello S., Rappaport J., Khalili K., Gordon J., Johnson E. M., SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. Journal of General Virology 2009 90 8 2005 2014 2-s2.0-69449104035 10.1099/vir.0.011072-0
57. Monaco M. C. G., Sabath B. F., Durham L. C., Major E. O., JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. Journal of Virology 2001 75 20 9687 9695 2-s2.0-0034812844 10.1128/JVI.75.20.9687-9695.2001 (Pubitemid 32900103)
58. White M. K., Johnson E. M., Khalili K., Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 2009 8 3 1 7 2-s2.0-63649099035
59. Wang H., White M. K., Kaminski R., Darbinian N., Amini S., Johnson E. M., Khalili K., Rappaport J., Role of Pur α in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. Anticancer Research 2008 28 3 A 1441 1447 (Pubitemid 351892915)
60. Berger J. R., Chauhan A., Galey D., Nath A., Epidemiological evidence and molecular basis of interactions between HIV and JC virus. Journal of NeuroVirology 2001 7 4 329 338 2-s2.0-0034834036 10.1080/13550280152537193 (Pubitemid 32894237)
61. Johnson T., Nath A., Immune reconstitution inflammatory syndrome and the central nervous system. Current Opinion in Neurology 2011 24 3 284 290 2-s2.0-79955615254 10.1097/WCO.0b013e328346be57
62. Gray F., Bazille C., Adle-Biassette H., Mikol J., Moulignier A., Scaravilli F., Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. Journal of NeuroVirology 2005 11 3 16 22 2-s2.0-33645055683 10.1080/13550280500511741
63. + T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology 2009 383 2 173 177 2-s2.0-58149117509 10.1016/j.virol.2008.10.046
64. Carson K. R., Focosi D., Major E. O., Petrini M., Richey E. A., West D. P., Bennett C. L., Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) project. The Lancet Oncology 2009 10 8 816 824 2-s2.0-67651158993 10.1016/S1470-2045(09)70161-5
65. Keene D. L., Legare C., Taylor E., Gallivan J., Cawthorn G. M., Vu D., Monoclonal antibodies and progressive multifocal leukoencephalopathy. The Canadian Journal of Neurological Sciences 2011 38 4 565 571
66. Edula R. G. R., Picco M. F., An evidence-based review of natalizumab therapy in the management of Crohn's disease. Therapeutics and Clinical Risk Management 2009 5 1 935 942 2-s2.0-77949452925
67. Neumann F., Zohren F., Haas R., The role of natalizumab in hematopoietic stem cell mobilization. Expert Opinion on Biological Therapy 2009 9 8 1099 1106 2-s2.0-67650682526 10.1517/14712590903055011
68. Krumbholz M., Meinl I., Kümpfel T., Hohlfeld R., Meinl E., Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 2008 71 17 1350 1354 2-s2.0-55449137632 10.1212/01.wnl.0000327671.91357.96
69. Marshall L. J., Dunham L., Major E. O., Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. The Journal of General Virology 2010 91 12 3042 3052 10.1099/vir.0.023184-0
70. + progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Multiple Sclerosis 2011 17 2 151 156 10.1177/1352458510385834
71. Lysandropoulos A. P., Du Pasquier R. A., Demyelination as a complication of new immunomodulatory treatments. Current Opinion in Neurology 2010 23 3 226 233 2-s2.0-77951968828 10.1097/WCO.0b013e3283398c96
72. Clifford D. B., DeLuca A., Simpson D. M., Arendt G., Giovannoni G., Nath A., Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. The Lancet Neurology 2010 9 4 438 446 2-s2.0-77949279537 10.1016/S1474-4422(10)70028-4
73. Tan I. L., McArthur J. C., Clifford D. B., Major E. O., Nath A., Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 2011 77 11 1061 1067
74. Cross A. H., Stark J. L., Lauber J., Ramsbottom M. J., Lyons J. A., Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. Journal of Neuroimmunology 2006 180 1-2 63 70 2-s2.0-33751085414 10.1016/j.jneuroim.2006.06.029 (Pubitemid 44767709)
75. Guttman-Yassky E., Vugmeyster Y., Lowes M. A., Chamian F., Kikuchi T., Kagen M., Gilleaudeau P., Lee E., Hunte B., Howell K., Dummer W., Bodary S. C., Krueger J. G., Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness. Journal of Investigative Dermatology 2008 128 5 1182 1191 2-s2.0-42149156689 10.1038/jid.2008.4 (Pubitemid 351543222)
76. Lebwohl M., Tyring S. K., Hamilton T. K., Toth D., Glazer S., Tawfik N. H., Walicke P., Dummer W., Wang X., Garovoy M. R., Pariser D., A novel targeted t-cell modulator, efalizumab, for plaque psoriasis. The New England Journal of Medicine 2003 349 21 2004 2013 2-s2.0-0345107256 10.1056/NEJMoa030002 (Pubitemid 37448923)
77. Krueger J. G., Ochs H. D., Patel P., Gilkerson E., Guttman-Yassky E., Dummer W., Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study. Journal of Investigative Dermatology 2008 128 11 2615 2624 2-s2.0-53949099628 10.1038/jid.2008.98
78. Berger J. R., Progressive multifocal leukoencephalopathy and newer biological agents. Drug Safety 2010 33 11 969 983
79. Kumar D., Bouldin T. W., Berger R. G., A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis and Rheumatism 2010 62 11 3191 3195 2-s2.0-78249286239 10.1002/art.27687
80. Gottlieb A. B., Chamian F., Masud S., Cardinale I., Abello M. V., Lowes M. A., Chen F., Magliocco M., Krueger J. G., TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. Journal of Immunology 2005 175 4 2721 2729 2-s2.0-23444432216 (Pubitemid 41113889)
81. Van den Brande J. M. H., Braat H., Van den Brink G. R., Versteeg H. H., Bauer C. A., Hoedemaeker I., Van Montfrans C., Hommes D. W., Peppelenbosch M. P., Van Deventer S. J. H., Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003 124 7 1774 1785 2-s2.0-0038047689 10.1016/S0016-5085(03) 00382-2 (Pubitemid 36666774)
82. Bellizzi A., Barucca V., Fioriti D., Colosimo M. T., Mischitelli M., Anzivino E., Chiarini F., Pietropaolo V., Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation. Journal of Cellular Physiology 2010 224 2 316 326 2-s2.0-77953623749 10.1002/jcp.22146
83. Ramos-Casals M., Roberto-Perez-Alvarez, Diaz-Lagares C., Cuadrado M. J., Khamashta M. A., Autoimmune diseases induced by biological agents. A double-edged sword? Autoimmunity Reviews 2010 9 3 188 193 2-s2.0-72149112759 10.1016/j.autrev.2009.10.003
84. Major E. O., Miller A. E., Mourrain P., Traub R. G., de Widt E., Sever J., Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proceedings of the National Academy of Sciences of the United States of America 1985 82 4 1257 1261 (Pubitemid 15100534)
85. Feigenbaum L., Khalili K., Major E., Khoury G., Regulation of the host range of human papovavirus JCV. Proceedings of the National Academy of Sciences of the United States of America 1987 84 11 3695 3698 2-s2.0-0023279744 (Pubitemid 17088348)
86. Amemiya K., Traub R., Durham L., Major E. O., Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain- specific genes. Journal of Biological Chemistry 1992 267 20 14204 14211 2-s2.0-0026639275
87. Ravichandran V., Major E. O., DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication. The Journal of General Virology 2008 89 6 1396 1401
88. Shinohara T., Nagashima K., Major E. O., Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology 1997 228 2 269 277 2-s2.0-18544393532 10.1006/viro.1996.8409 (Pubitemid 27238794)
89. Gosert R., Kardas P., Major E. O., Hirsch H. H., Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. Journal of Virology 2010 84 20 10448 10456 2-s2.0-77957195722 10.1128/JVI.00614-10
90. Wegner M., Drolet D. W., Rosenfeld M. G., Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences of the United States of America 1993 90 10 4743 4747 2-s2.0-0027207579 (Pubitemid 23148982)
91. Chen N. N., Khalili K., Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur α in glial cells. Journal of Virology 1995 69 9 5843 5848 2-s2.0-0029162427
92. Shivakumar C. Y., Das G. C., Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function. Journal of General Virology 1994 75 6 1281 1290 2-s2.0-0028176687
93. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F., Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. Journal of Virology 1990 64 6 3139 3143 (Pubitemid 20171319)
94. Ault G. S., Activity of JC virus archetype and PML-type regulatory regions in glial cells. Journal of General Virology 1997 78 1 163 169 2-s2.0-0031023677 (Pubitemid 27067527)
95. Ravichandran V., Sabath B. F., Jensen P. N., Houff S. A., Major E. O., Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. Journal of Virology 2006 80 21 10506 10513 2-s2.0-33750375708 10.1128/JVI.01355-06 (Pubitemid 44628897)
96. Safak M., Gallia G. L., Khalili K., A 23-bp sequence element from human neurotropic JC virus is responsive to NF- B subunits. Virology 1999 262 1 178 189 2-s2.0-0033568281 10.1006/viro.1999.9886 (Pubitemid 29455015)
97. Kumar K. U., Devireddy L. R., Tang S. C., Pater A., Pater M. M., Human JC virus nuclear factor 1 binding motifs and large tumor antigen region required for transactivation of late promoter. Journal of Neurochemistry 1996 67 2 473 481 2-s2.0-0030055607 (Pubitemid 26255639)
98. Safak M., Gallia G. L., Khalili K., Reciprocal interaction between two cellular proteins, Pur α and YB-1, modulates transcriptional activity of JCV(CY) in glial cells. Molecular and Cellular Biology 1999 19 4 2712 2723 2-s2.0-0032964375 (Pubitemid 29144515)
99. Safak M., Khalili K., Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. Journal of NeuroVirology 2001 7 4 288 292 2-s2.0-0034827329 10.1080/13550280152537111 (Pubitemid 32894229)
100. Kim H. S., Goncalves N. M., Henson J. W., Glial cell-specific regulation of the JC virus early promoter by large T antigen. Journal of Virology 2000 74 2 755 763 2-s2.0-0033986356 10.1128/JVI.74.2.755-763.2000 (Pubitemid 30036211)
101. Shrikant P., Benveniste E. N., The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. Journal of Immunology 1996 157 5 1819 1822 2-s2.0-0030240326 (Pubitemid 126449650)
102. Malone K. E., Stohlman S. A., Ramakrishna C., Macklin W., Bergmann C. C., Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. GLIA 2008 56 4 426 435 2-s2.0-38949145795 10.1002/glia.20625 (Pubitemid 351212951)
103. Mack C. L., Vanderlugt-Castaneda C. L., Neville K. L., Miller S. D., Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Journal of Neuroimmunology 2003 144 1-2 68 79 2-s2.0-0142258022 10.1016/j.jneuroim.2003.08.032 (Pubitemid 37329931)
104. Ousman S. S., Kubes P., Immune surveillance in the central nervous system. Nature Neuroscience 2012 15 8 1096 1101
105. Ransohoff R. M., Kivisäkk P., Kidd G., Three or more routes for leukocyte migration into the central nervous system. Nature Reviews Immunology 2003 3 7 569 581 10.1038/nri1130 (Pubitemid 37328676)
106. + lymphocytes. Neuropathology 2011 31 3 230 238 2-s2.0-79957558474 10.1111/j.1440-1789.2010.01167.x
107. Laschinger M., Vajkoczy P., Engelhardt B., Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. European Journal of Immunology 2002 32 12 3598 3606 (Pubitemid 36024396)
108. Mukerjee R., Sawaya B. E., Khalili K., Amini S., Association of p65 and C/EBP β with HIV-1 LTR modulates transcription of the viral promoter. Journal of Cellular Biochemistry 2007 100 5 1210 1216 2-s2.0-33947589854 10.1002/jcb.21109 (Pubitemid 46480403)
109. Gorrill T. S., Khalili K., Cooperative interaction of p65 and C/EBP β modulates transcription of BKV early promoter. Virology 2005 335 1 1 9 2-s2.0-16844374279 10.1016/j.virol.2005.02.006 (Pubitemid 40489047)
110. Nagano I., Nakamura S., Yoshioka M., Onodera J., Kogure K., Itoyama Y., Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994 44 4 710 715 2-s2.0-0028221129 (Pubitemid 24130004)
111. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., Kumegawa M., Kimura T., Takeya T., Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. Journal of Biological Chemistry 2002 277 43 41147 41156 2-s2.0-0037174944 10.1074/jbc.M205063200 (Pubitemid 35215706)
112. Marzocchetti A., Wuthrich C., Tan C. S., Tompkins T., Bernal-Cano F., Bhargava P., Ropper A. H., Koralnik I. J., Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2008 14 5 455 458 2-s2.0-57049182365 10.1080/13550280802356837 (Pubitemid 352762885)
113. Tan C. S., Dezube B. J., Bhargava P., Autissier P., Wüthrich C., Miller J., Koralnik I. J., Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. Journal of Infectious Diseases 2009 199 6 881 888 2-s2.0-65649083713 10.1086/597117
114. Darbinyan A., White M. K., Akan S., Radhakrishnan S., Del Valle L., Amini S., Khalili K., Alterations of DNA damage repair pathways resulting from JCV infection. Virology 2007 364 1 73 86 2-s2.0-34249686128 10.1016/j.virol.2007.02. 015 (Pubitemid 46829277)
115. Sock E., Enderich J., Wegner M., The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP. Molecular and Cellular Biology 1999 19 4 2455 2464 2-s2.0-0032957286 (Pubitemid 29144489)
116. Hara K., Sugimoto C., Kitamura T., Aoki N., Taguchi F., Yogo Y., Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen. Journal of Virology 1998 72 7 5335 5342 2-s2.0-0031778409 (Pubitemid 28283312)
117. Jensen P. N., Major E. O., A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. Journal of NeuroVirology 2001 7 4 280 287 2-s2.0-0034833867 10.1080/13550280152537102 (Pubitemid 32894228)
118. Agostini H. T., Ryschkewitsch C. F., Stoner G. L., Rearrangements of archetypal regulatory regions in JC virus genomes from urine. Research in Virology 1998 149 3 163 170 2-s2.0-0032078510 10.1016/S0923-2516(98)80034-4 (Pubitemid 28346494)
119. Delbue S., Sotgiu G., Fumagalli D., Valli M., Borghi E., Mancuso R., Marchioni E., Maserati R., Ferrante P., A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. Journal of NeuroVirology 2005 11 1 51 57 2-s2.0-16244405913 10.1080/13550280590900382 (Pubitemid 40458371)
120. Reid C. E., Li H., Sur G., Carmillo P., Bushnell S., Tizard R., McAuliffe M., Tonkin C., Simon K., Goelz S., Cinque P., Gorelik L., Carulli J. P., Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. Journal of Infectious Diseases 2011 204 2 237 244 10.1093/infdis/jir256
121. Marshall L. J., Moore L. D., Mirsky M. M., Major E. O., JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes. The Journal of General Virology 2011 93 3 651 661
122. Roux D., Bouldouyre M. A., Mercier-Delarue S., Seilhean D., Zagdanski A. M., Delaugerre C., Simon F., Molina J. M., Legoff J., JC virus variant associated with cerebellar atrophy in a patient with AIDS. Journal of Clinical Microbiology 2011 49 6 2196 2199 2-s2.0-79957496469 10.1128/JCM.02057-10
123. Sidhu N., McCutchan J. A., Unmasking of PML by HAART: unusual clinical features and the role of IRIS. Journal of Neuroimmunology 2010 219 1-2 100 104 2-s2.0-77249153621 10.1016/j.jneuroim.2009.11.013
124. Chapagain M. L., Verma S., Mercier F., Yanagihara R., Nerurkar V. R., Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 2007 364 1 55 63 2-s2.0-34249661722 10.1016/j.virol.2007.02.018 (Pubitemid 46829276)